AMRUTANJAN
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Amrutanjan Health Care Dividend 1 Rupee Per Share
Nov 12 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
AMRUTANJAN HEALTH CARE LTD - DIVIDEND 1 RUPEE PER SHARE
Source text: [ID:]
Further company coverage: AJAN.NS
(([email protected];))
Nov 12 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
AMRUTANJAN HEALTH CARE LTD - DIVIDEND 1 RUPEE PER SHARE
Source text: [ID:]
Further company coverage: AJAN.NS
(([email protected];))
Amrutanjan Health Care Ltd - Dividend 2.6 Rupeesper Share
Amrutanjan Health Care Ltd AJAN.NS:
AMRUTANJAN HEALTH CARE LTD - DIVIDEND 2.6 RUPEESPER SHARE
AMRUTANJAN HEALTH CARE LTD MARCH-QUARTER PAT 136.6 MILLION RUPEES VERSUS 127 MILLION RUPEES
AMRUTANJAN HEALTH CARE LTD MARCH-QUARTER REVENUE FROM OPERATIONS 1.27 BILLION RUPEES VERSUS 1 BILLION RUPEES
Source text for Eikon: ID:nNSE19v9Xf
Further company coverage: AJAN.NS
Amrutanjan Health Care Ltd AJAN.NS:
AMRUTANJAN HEALTH CARE LTD - DIVIDEND 2.6 RUPEESPER SHARE
AMRUTANJAN HEALTH CARE LTD MARCH-QUARTER PAT 136.6 MILLION RUPEES VERSUS 127 MILLION RUPEES
AMRUTANJAN HEALTH CARE LTD MARCH-QUARTER REVENUE FROM OPERATIONS 1.27 BILLION RUPEES VERSUS 1 BILLION RUPEES
Source text for Eikon: ID:nNSE19v9Xf
Further company coverage: AJAN.NS
Amrutanjan Health Care Approved Project To Set Up New Plant For Manufacturing Sanitary Napkins At Estimated Cost Of 1.23 Billion Rupees
May 1 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
APPROVED PROJECT TO SET UP NEW PLANT FOR MANUFACTURING SANITARY NAPKINS AT ESTIMATED COST OF 1.23 BILLION RUPEES
Source text for Eikon: ID:nNSE8vKtdh
Further company coverage: AJAN.NS
(([email protected];))
May 1 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
APPROVED PROJECT TO SET UP NEW PLANT FOR MANUFACTURING SANITARY NAPKINS AT ESTIMATED COST OF 1.23 BILLION RUPEES
Source text for Eikon: ID:nNSE8vKtdh
Further company coverage: AJAN.NS
(([email protected];))
India's Amrutanjan Health Care jumps on Q3 profit rise
** Shares of healthcare products maker Amrutanjan Health Care AJAN.NS up 11.1% to 652 rupees, their highest rise since July 2023 and steepest intraday gain since early 2021
** Co reported a ~63% rise in profit for the quarter ended Dec 31, rev from ops grew ~20%
** AJAN sees busiest trading day since June 2023; volumes at 16.2x the 30-day avg
** Shares tanked ~16% in 2023
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of healthcare products maker Amrutanjan Health Care AJAN.NS up 11.1% to 652 rupees, their highest rise since July 2023 and steepest intraday gain since early 2021
** Co reported a ~63% rise in profit for the quarter ended Dec 31, rev from ops grew ~20%
** AJAN sees busiest trading day since June 2023; volumes at 16.2x the 30-day avg
** Shares tanked ~16% in 2023
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Amrutanjan Health Care Dec-Quarter PAT Roses
Feb 9 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
DEC-QUARTER PAT 174.5 MILLION RUPEES VERSUS PROFIT 107.1 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 1.17 BILLION RUPEES VERSUS 976.5 MILLION RUPEES
Source text for Eikon: ID:nNSE5fjFh3
Further company coverage: AJAN.NS
(([email protected];))
Feb 9 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
DEC-QUARTER PAT 174.5 MILLION RUPEES VERSUS PROFIT 107.1 MILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 1.17 BILLION RUPEES VERSUS 976.5 MILLION RUPEES
Source text for Eikon: ID:nNSE5fjFh3
Further company coverage: AJAN.NS
(([email protected];))
Amrutanjan Health Care Declared First Interim Dividend Of 1 Rupeesper Share
Nov 10 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
RECOMMENDED RE-APPOINTMENT OF S. SAMBHU PRASAD AS CHAIRMAN AND MANAGING DIRECTOR
DECLARED FIRST INTERIM DIVIDEND OF 1 RUPEESPER SHARE
Source text for Eikon: ID:nNSEbln8Yv
Further company coverage: AJAN.NS
(([email protected];))
Nov 10 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
RECOMMENDED RE-APPOINTMENT OF S. SAMBHU PRASAD AS CHAIRMAN AND MANAGING DIRECTOR
DECLARED FIRST INTERIM DIVIDEND OF 1 RUPEESPER SHARE
Source text for Eikon: ID:nNSEbln8Yv
Further company coverage: AJAN.NS
(([email protected];))
Amrutanjan Health Care Gives Update On Investigation Initiated By Co On Anonymous Whistle Blower Complaint
Aug 2 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
UPDATE ON INVESTIGATION INITIATED BY CO ON ANONYMOUS WHISTLE BLOWER COMPLAINT
HAD ENGAGED DELOITTE TOUCHE TOHMATSU INDIA LLP FOR UNDERTAKING THE INVESTIGATION IN THIS REGARD
INVESTIGATION WAS RECENTLY CONCLUDED
AUDIT PROCESS HAS BROUGHT INTO LIGHT, FEW ACTS OF PERSONAL GAINS BY CO EMPLOYEES
FINDINGS DO NOT HAVE ANY SUBSTANTIAL IMPACT ON FINANCIAL STATEMENTS OR THE OVERALL FINANCIAL HEALTH CO
Source text for Eikon: ID:nBSE6JT1Cc
Further company coverage: AJAN.NS
(([email protected];))
Aug 2 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
UPDATE ON INVESTIGATION INITIATED BY CO ON ANONYMOUS WHISTLE BLOWER COMPLAINT
HAD ENGAGED DELOITTE TOUCHE TOHMATSU INDIA LLP FOR UNDERTAKING THE INVESTIGATION IN THIS REGARD
INVESTIGATION WAS RECENTLY CONCLUDED
AUDIT PROCESS HAS BROUGHT INTO LIGHT, FEW ACTS OF PERSONAL GAINS BY CO EMPLOYEES
FINDINGS DO NOT HAVE ANY SUBSTANTIAL IMPACT ON FINANCIAL STATEMENTS OR THE OVERALL FINANCIAL HEALTH CO
Source text for Eikon: ID:nBSE6JT1Cc
Further company coverage: AJAN.NS
(([email protected];))
Amrutanjan Health Care Shall Not Raise Further Capital For A Period Of One Year From Expiry Of Buyback Period
June 30 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
CO SHALL NOT RAISE FURTHER CAPITAL FOR A PERIOD OF ONE YEAR FROM EXPIRY OF BUYBACK PERIOD
Source text for Eikon: ID:nNSE1BxxWr
Further company coverage: AJAN.NS
(([email protected];))
June 30 (Reuters) - Amrutanjan Health Care Ltd AJAN.NS:
CO SHALL NOT RAISE FURTHER CAPITAL FOR A PERIOD OF ONE YEAR FROM EXPIRY OF BUYBACK PERIOD
Source text for Eikon: ID:nNSE1BxxWr
Further company coverage: AJAN.NS
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Split
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Amrutanjan Healthcar do?
Amrutanjan Health Care Ltd manufactures a variety of ayurvedic and allopathic products available in several countries worldwide. The company also plans to expand into the US and European markets with a diverse product portfolio including pain relief products, ointments, and supplements.
Who are the competitors of Amrutanjan Healthcar?
Amrutanjan Healthcar major competitors are Max India, Sastasundar Ventures, Rajnish Wellness, Cupid, Medplus Health Servi, Jeena Sikho Life, Krsnaa Diagnostics. Market Cap of Amrutanjan Healthcar is ₹2,095 Crs. While the median market cap of its peers are ₹2,516 Crs.
Is Amrutanjan Healthcar financially stable compared to its competitors?
Amrutanjan Healthcar seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Amrutanjan Healthcar pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Amrutanjan Healthcar latest dividend payout ratio is 26.16% and 3yr average dividend payout ratio is 29.83%
How has Amrutanjan Healthcar allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Amrutanjan Healthcar balance sheet?
Balance sheet of Amrutanjan Healthcar is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Amrutanjan Healthcar improving?
Yes, profit is increasing. The profit of Amrutanjan Healthcar is ₹54.53 Crs for TTM, ₹50.83 Crs for Mar 2025 and ₹44.97 Crs for Mar 2024.
Is the debt of Amrutanjan Healthcar increasing or decreasing?
The net debt of Amrutanjan Healthcar is decreasing. Latest net debt of Amrutanjan Healthcar is -₹166.28 Crs as of Mar-25. This is less than Mar-24 when it was -₹53.17 Crs.
Is Amrutanjan Healthcar stock expensive?
Amrutanjan Healthcar is not expensive. Latest PE of Amrutanjan Healthcar is 38.42, while 3 year average PE is 41.25. Also latest EV/EBITDA of Amrutanjan Healthcar is 31.88 while 3yr average is 35.55.
Has the share price of Amrutanjan Healthcar grown faster than its competition?
Amrutanjan Healthcar has given lower returns compared to its competitors. Amrutanjan Healthcar has grown at ~-0.71% over the last 3yrs while peers have grown at a median rate of 18.29%
Is the promoter bullish about Amrutanjan Healthcar?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Amrutanjan Healthcar is 46.52% and last quarter promoter holding is 46.52%.
Are mutual funds buying/selling Amrutanjan Healthcar?
The mutual fund holding of Amrutanjan Healthcar is stable. The current mutual fund holding in Amrutanjan Healthcar is 7.55% while previous quarter holding is 7.55%.